Multidrug Resistance: the Clinical Dilemma of Refractory Helicobacter Pylori Infection.
Journal of Microbiology, Immunology and Infection(2021)
摘要
This study investigated the antimicrobial resistance of isolates from patients with refractory Helicobacter pylori. The resistance rate was 34.1% for amoxicillin, 92.7% for clarithromycin, 65.9% for metronidazole, 85.4% for levofloxacin, and 29.3% for rifabutin. Dual resistance to both clarithromycin and levofloxacin was found in 73.2%. The antimicrobial resistance rate of refractory H. pylori was extremely high, which had become a major consideration in therapeutic challenge.
更多查看译文
关键词
Refractory H,pylori,Antimicrobial susceptibility,Resistance rate
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要